Takanori Watanabe
Fukuoka, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Activated factor X inhibition ameliorates NF-κB-IL-6-mediated perivascular inflammation and pulmonary hypertension.
Journal: American journal of physiology. Lung cellular and molecular physiology
Published: June 13, 2025
Delayed manifestation of severe coronary artery injury/stenosis associated with cavo-tricuspid isthmus ablation: a case report.
Journal: European heart journal. Case reports
Published: August 05, 2024
Increased Lung Uric Acid Deteriorates Pulmonary Arterial Hypertension.
Journal: Journal of the American Heart Association
Published: November 30, 2021
Chronic Inhibition of Toll-Like Receptor 9 Ameliorates Pulmonary Hypertension in Rats.
Journal: Journal of the American Heart Association
Published: March 31, 2021
Inhibition of TLR9-NF-κB-mediated sterile inflammation improves pressure overload-induced right ventricular dysfunction in rats.
Journal: Cardiovascular research
Published: January 18, 2018
Subcutaneous treprostinil was effective and tolerable in a patient with severe pulmonary hypertension associated with chronic kidney disease on hemodialysis.
Journal: Heart & lung : the journal of critical care
Published: December 22, 2016
A case of coronary subclavian vertebral steal syndrome successfully treated with stenting to the stenosis of left subclavian artery.
Journal: Journal of cardiology cases
Published: April 12, 2016
A case of Kounis syndrome associated with transcatheter arterial chemoembolization for hepatocellular carcinoma.
Journal: Journal of cardiology cases
Published: April 02, 2015
Spatial Confidence Regions for Quantifying and Visualizing Registration Uncertainty.
Journal: Biomedical image registration, ... proceedings. WBIR (Workshop : 2006- )
Published: January 01, 2012
Showing 1-9 of 9
Last Updated: 09/26/2026